Kiniksa Pharmaceuticals International (KNSA) Tax Rate Growth (3y) (2020 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Tax Rate Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Kiniksa Pharmaceuticals International | 4.95 Bn | 4.48 Bn | 193.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,190.00 |
| Dec 31, 2025 | 16,485.00 |
| Sep 30, 2025 | 41,161.00 |
| Jun 30, 2025 | 2,577.00 |
| Mar 31, 2025 | 5,341.00 |
| Dec 31, 2024 | -6,975.00 |
| Sep 30, 2024 | -7,665.00 |
| Jun 30, 2024 | 27,212.00 |
| Mar 31, 2024 | -2,359.00 |
| Dec 31, 2023 | -1,378.00 |
| Sep 30, 2023 | -6,147.00 |
| Dec 31, 2022 | -21,139.00 |
| Mar 31, 2022 | -829.00 |
| Dec 31, 2021 | 119.00 |
| Jun 30, 2021 | -349.00 |
| Mar 31, 2021 | -76.00 |
| Dec 31, 2020 | -112.00 |
| Sep 30, 2020 | -186.00 |